Program Highlights
The Nordic Life Science Days presents a thoughtfully curated program that provides a preview of the upcoming developments in the life science industry for the year.

NLSDays Main Theme:
Where Nordic Life Science Meets the World
The conference topics are carefully selected to reflect current trends in the life science industry, focusing on areas where Nordic excellence aligns with global interest.
The two-day conference program features a variety of engaging session formats:

Supersessions
are panel discussions addressing hot topics in life science. Each session features representatives from pharma, investment, biotech, and medtech companies discussing the latest industry advancements.

Interactive Workshops
explore specific themes in greater depth. Sponsored by participating companies, these sessions offer a platform to demonstrate expertise and thought leadership.

Global Insights and Company Presentations
provide the opportunity for individual companies or regional clusters to highlight their unique strengths and market positioning.

Pitch Competition
gives early-stage companies a chance to present their ventures on a high-profile stage.

Poster Session
invites academics and startups to showcase their innovation potential in a visual and engaging format.
Plan your week at NLSDays
Arrival:
Arrive in Gothenburg by Sunday, October 12th, to make the most out of NLSDays 2025. You can collect your badge from 14:00 onwards.
Departure:
The program will end at 17:30 on Tuesday, October 14th. Side events are scheduled for Wednesday, October 15th, between 09:00 and 15:00.
2025 Session Topics
This year’s topics underscores its crucial role in fostering collaboration and driving innovation within the Nordic ecosystem – uniquely convening stakeholders from emerging biotechs to global pharmaceutical companies and investors, all in one dynamic space.
Transforming CVRM Health: The Future of Metabolic Medicine
Supersession
Cardiovascular, Renal, and Metabolic (CVRM) health is a rapidly evolving field that holds significant promise for improving patient outcomes and advancing medical science. This session will delve into the latest research, innovative treatments, and emerging technologies that are shaping the future of CVRM and metabolic health. Join us to hear from renowned industry leaders and investors working at the forefront of innovation in this field providing valuable insights into the future of CVRM and metabolic health.
TechBio – Where Biology Meets Deep Tech
Supersession
TechBio is transforming the life science landscape by fusing biology with cutting-edge technologies such as artificial intelligence, machine learning, big data, quantum computing, and automation. This session dives into how this convergence is not only accelerating drug discovery and development but also reshaping how we understand, diagnose, and treat disease. Executives from pioneering companies and investment firms will explore how this new wave of innovation is unlocking novel biological insights and whether the Nordic region has unique position.
New Frontiers in Neuroscience
Supersession
Central Nervous System (CNS) disorders remain among the most complex and urgent challenges in global healthcare. This session will spotlight the latest advancements in CNS research and development, highlighting breakthroughs in areas such as neuroinflammation, gene and cell therapies, biomarkers, and digital therapeutics. Experts from biotech, pharma, and investor will share cutting-edge approaches and discuss how technological convergence is accelerating the path from discovery to treatment.
Culture as a Competitive Advantage – A Nordic Perspective
Supersession
In the Nordic life science ecosystem, culture isn’t just an internal value—it’s a strategic force. Rooted in principles of trust, equality, sustainability, and collaboration, the Nordics are uniquely positioned to harness culture as a true competitive advantage on the global stage. This session explores how the distinct values embedded in Nordic working culture foster innovation, attract international talent, and build resilient organizations. Through real-world examples and insights from leading life science companies, we’ll uncover how cultural strengths can translate into global business success.
Financing the Future of Life Science – Strategies, Trends, and Opportunities
Supersession
In today’s fast-evolving biotech and medtech landscape, access to capital is as critical as scientific innovation. This supersession brings together leading investors, financial strategists, and venture capitalists to explore the current and future state of financing in the sector.